PDCD1 and colorectal carcinoma: The efficacy of ICB therapy targeting programmed cell death 1 (PD-1) or cytotoxic T-lymphocyte associated protein 4 (CTLA-4) was limited in CRC, so we examined the predictive and immunotherapeutic efficacy of IRScore.